This may sound strange but on some level antiviral drug research is "easy." Make that "easy compared to other therapeutic areas," because those who do research in the antiviral field – something I did for 10 years – have an advantage over scientis
Respiratory Syncytial Virus
It is not every day that drug development results in a breakthrough with the potential to eliminate an often serious and sometimes fatal disease, but one of those days occurred early last month.